NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.

Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

9144) which eliminates the funding cap for New York’s Spinal Cord Injury Research Program was signed by the ... affecting the healthcare for the many New York children who rely on SBHC’s for primary ...

Scientists traced connectivity between neurons to identify how the brain communicates with the spinal cord to control motor function.

After eight weeks of intensive rehab at the Cleveland Clinic in Central London during which time he had made a significant ...

After a seven-year hiatus from football because of a life-changing injury, Shazier returns to his former team.

In 2014, a car crash in New Zealand left the then 31-year-old Jean Ling with a serious spinal cord injury. When she woke up, ...

Onward Medical announced today that it received FDA de novo clearance for its ARC-EX spinal cord stimulation (SCS) system.

Shares in the company were up 7% at market open following the first approval for a non-invasive spinal cord stimulator for ...

As we come to the end of the year, we reflect and revisit the most read College of Medicine and Health news stories on our website.

A Phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the long-term safety and ...

A Phase I clinical trial has demonstrated the long-term safety of neural stem cell transplantation for chronic spinal cord ...